Antimicrobial Resistance Global Health Threat

Passage

Antimicrobial resistance, broadly defined as the capacity of microorganisms including bacteria, viruses, fungi, and parasites to survive and proliferate in the presence of drugs previously effective in eliminating them, has been identified by the World Health Organization as one of the most serious global public health threats of the twenty-first century, with projections suggesting that drug-resistant infections could cause ten million deaths annually by 2050 if current trends continue unchecked. The accelerating emergence of resistance is driven by multiple interconnected factors, including the overuse and inappropriate prescription of antibiotics in human medicine, the widespread prophylactic administration of antimicrobials in livestock agriculture to promote growth and prevent disease in densely housed animals, inadequate infection prevention and control measures in healthcare settings, and insufficient investment in the research and development of novel antimicrobial agents by pharmaceutical companies deterred by limited commercial returns. The consequences extend beyond infectious disease mortality, threatening the safety of routine surgical procedures, organ transplantation, cancer chemotherapy, and premature infant care, all of which rely heavily on effective antibiotic prophylaxis. International coordination through initiatives such as national action plans and stewardship programmes is considered essential for slowing resistance development, though enforcement mechanisms and equitable access to existing effective drugs remain significant challenges across low- and middle-income countries.